Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Difficulties with emotion regulation in multiple sclerosis: Links to executive function, mood, and quality of life.
Technical developments of functional electrical stimulation to correct drop foot: Sensing, actuation and control strategies.
Aptamer Oligonucleotides: Novel Potential Therapeutic Agents in Autoimmune Disease.
Inflammasomes and human autoimmunity: A comprehensive review.
The Swedish MS registry - clinical support tool and scientific resource.
Fingolimod prevents blood-brain barrier disruption induced by the sera from patients with multiple sclerosis.
Neuromyelitis optica spectrum disorders: beyond longitudinally extensive transverse myelitis.
Pregnancy-related relapse risk factors in women with anti-AQP4 antibody positivity and neuromyelitis optica spectrum disorder.
Clinicopathological features in anterior visual pathway in neuromyelitis optica.
THC:CBD Observational Study Data: Evolution of Resistant MS Spasticity and Associated Symptoms.
The potential role of pharmacogenomics in the prevention of serious adverse drug reactions in multiple sclerosis.
[Fingolimod therapy in multiple sclerosis--the issue of the pathomechanism].
Sex-related differences in atrophy and lesion load in multiple sclerosis patients.
The relationship of cognitive impairment with neurological and psychiatric variables in multiple sclerosis patients.
Intra-individual variability in information processing speed reflects white matter microstructure in multiple sclerosis.
Axonal Guillain-Barré syndrome: concepts and controversies.
Iron chelation and multiple sclerosis.
Intranetwork and internetwork functional connectivity abnormalities in pediatric multiple sclerosis.
IL-27 Limits Central Nervous System Viral Clearance by Promoting IL-10 and Enhances Demyelination.
Acute symptomatic sinus bradycardia in a woman treated with pulse dose steroids for multiple sclerosis: a case report.
Retinal hemorrhages following fingolimod treatment for multiple sclerosis; a case report.
Stem Cell Ophthalmology Treatment Study (SCOTS) for retinal and optic nerve diseases: a case report of improvement in relapsing auto-immune optic neuropathy.
A longitudinal study of cortical grey matter lesion subtypes in relapse-onset multiple sclerosis.
A case of neuromyelitis optica spectrum disorder presenting with severe orthostatic hypotension.
Subject-Specific Sparse Dictionary Learning for Atlas-Based Brain MRI Segmentation.
Pages
« first
‹ previous
…
447
448
449
450
451
452
453
454
455
…
next ›
last »